Phellinus igniarius: A Pharmacologically Active Polypore Mushroom

Area of Science:

• Mycology
• Pharmacology
• Immunology

Background:

• Mushrooms, particularly polypores (Basidiomycota), have a long history in traditional medicine.
• Scientific research increasingly validates the therapeutic properties of mushrooms.
• Phellinus igniarius is a traditional Asian medicine mushroom renowned for its anticancer effects.

Purpose of the Study:

• To investigate the pharmacological activities of Phellinus igniarius.
• To identify and characterize active compounds responsible for its therapeutic effects.
• To understand the mechanisms of Phellinus igniarius in modulating immune responses and inhibiting tumor growth.

Main Methods:

• Isolation and identification of pharmacologically active metabolites from Phellinus igniarius.
• Characterization of polysaccharides as the most active compounds.
• Evaluation of the immunomodulatory and anti-tumor properties of these compounds.

Main Results:

• Numerous active metabolites have been isolated from Phellinus igniarius over the past two decades.
• Polysaccharides were identified as a major group of pharmacologically active compounds.
• These polysaccharides demonstrate the ability to modulate immune responses and inhibit tumor growth.

Conclusions:

• Phellinus igniarius possesses significant anticancer properties attributed to its active metabolites, particularly polysaccharides.
• Polysaccharides from Phellinus igniarius offer a promising avenue for developing novel immunotherapies and anti-cancer treatments.
• Further research into mushroom-derived compounds can advance both traditional medicine and modern pharmacology.